search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Galderma's Differin Goes OTC, CoolSculpting Approved for Upper Arms, ZO Skin Acquires ReFissa

February 8, 2017

Galderma's Differin Gel formulation of adapalene 0.1% is now available over the counter at major retail and drug stores in the US. ZELTIQ® Aesthetics' CoolSculpting is now FDA-cleared for fat reduction in the upper arms. ZO Skin Health has acquired the worldwide rights to ReFissa from Suneva Medical. Valeant Dermatology will be awarding nine individual scholarships of up to $10,000 through its annual ASPIRE HIGHER Scholarship Program.

Advertisement

In This Series

View More

Advertisement